ARGENX SE's ticker is ARGX and the CUSIP is 04016X101. A total of 269 filers reported holding ARGENX SE in Q4 2022. The put-call ratio across all filers is 0.88 and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $13,503 | +32.7% | 27,466 | +5.2% | 0.08% | +38.2% |
Q2 2023 | $10,173 | +42.1% | 26,102 | +35.9% | 0.06% | +34.1% |
Q1 2023 | $7,157 | -5.4% | 19,208 | -3.8% | 0.04% | -14.6% |
Q4 2022 | $7,567 | -99.7% | 19,975 | +166.3% | 0.05% | +269.2% |
Q1 2022 | $2,365,000 | -4.9% | 7,500 | +5.6% | 0.01% | +8.3% |
Q4 2021 | $2,486,000 | -3.2% | 7,100 | -16.5% | 0.01% | -7.7% |
Q3 2021 | $2,567,000 | +0.3% | 8,500 | 0.0% | 0.01% | 0.0% |
Q2 2021 | $2,559,000 | +4.4% | 8,500 | -4.5% | 0.01% | -7.1% |
Q1 2021 | $2,451,000 | -15.8% | 8,900 | -10.1% | 0.01% | -22.2% |
Q4 2020 | $2,911,000 | +13.1% | 9,900 | +1.0% | 0.02% | -5.3% |
Q3 2020 | $2,573,000 | -28.6% | 9,800 | -38.8% | 0.02% | +26.7% |
Q2 2020 | $3,604,000 | – | 16,000 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SAL Trading, LLC | 36,100 | $17,747,843 | 24.88% |
Artia Global Partners LP | 49,238 | $24,206,878 | 10.06% |
Paradigm Biocapital Advisors LP | 261,443 | $128,533,222 | 8.72% |
Darwin Global Management, Ltd. | 45,615 | $22,425,702 | 7.89% |
Avoro Capital Advisors LLC | 1,000,000 | $491,630,000 | 7.67% |
Bellevue Group AG | 911,530 | $448,135,494 | 7.22% |
Eagle Health Investments LP | 64,400 | $31,660,972 | 6.98% |
DCF Advisers, LLC | 22,000 | $10,815,860 | 5.89% |
SAL Trading, LLC | 8,149 | $4,006,293 | 5.62% |
RTW INVESTMENTS, LP | 507,195 | $249,352,278 | 5.26% |